pillbase.ru

Tezspire

Active substance: tezepelumab

tezepelumab

Centralised EU authorisationActive

Marketing holder: AstraZeneca AB

Verified 2026-10-09 · EMA

Analogues in other countries
Composition
Analogues by country

Products with the same active substance registered in other countries.

CountryProducts
US 2
  • TEZSPIRE
    INJECTION, SOLUTION · TEZEPELUMAB 210 mg/1.9mL
    55513-123
    Amgen Inc
  • TEZSPIRE
    INJECTION, SOLUTION · TEZEPELUMAB 210 mg/1.9mL
    55513-112
    Amgen Inc
Import and control

Control by country

  • United Statesprescription only

    Source: openFDA NDC · record 01a12093-c3b5-7c78-8e1d-eea4a3c4da95,01a1209d-8cd1-7b3a-a70c-c0ae8d47996f;count=2 · valid from 2026-10-09 · verified 2026-10-09

More on control status
Registration
Registration number
EMEA/H/C/005588
Registration status
Active
ATC code
R03DX11
Sources
  • product · EMA · EMEA/H/C/005588 · Verified 2026-10-09
  • registration_status · EMA · EMEA/H/C/005588 · Verified 2026-10-09
  • ingredients.0 · EMA · EMEA/H/C/005588 · Verified 2026-10-09